Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes
Department of Pediatrics; Senior Scholars Program
Base Sequence; Child; Child, Preschool; Fathers; Genetic Predisposition to Disease; *Haplotypes; Humans; Infant; Inheritance Patterns; Leukocyte Elastase; Male; *Mutation; Neutropenia; Pedigree; Phenotype; Spermatozoa
Hematology | Oncology | Pediatrics
BACKGROUND: Cyclic neutropenia (CN) and severe congenital neutropenia (SCN) are disorders of neutrophil production that differ markedly in disease severity. Mutations of the ELANE gene (the symbol recently replacing ELA2) are considered largely responsible for most cases of CN and SCN, but specific mutations are typically associated with one or the other.
PROCEDURE: We performed ELANE genotyping on all individuals and paternal sperm in an SCN kindred with eight SCN progeny of a sperm donor and six different mothers. RESULTS: One patient with CN had the same S97L ELANE mutation as seven patients with the SCN phenotype. The mutant allele was detected in the donor's spermatozoa, representing 18% of the ELANE gene pool, but not in DNA from his lymphocytes, neutrophils, or buccal mucosa, indicating gonadal mosaicism.
CONCLUSIONS: The coexistence of CN and SCN phenotypes in this kindred with a shared paternal haplotype strongly suggests both a role for modifying genes in determination of congenital neutropenia disease phenotypes, and the classification of CN and SCN within a spectrum of phenotypes expressing varying degrees of the same disease process.
DOI of Published Version
Pediatr Blood Cancer. 2010 Aug;55(2):314-7. Link to article on publisher's website
Pediatric blood and cancer
Newburger, Peter E.; Pindyck, Talia N.; Zhu, Zhiqing; Bolyard, Audrey Anna; Aprikyan, Andrew A.G.; Dale, David C.; Smith, Gary D.; and Boxer, Laurence A., "Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes" (2010). Hematology/Oncology. 130.